"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...

It also accuses the federal government of failing to "provide sufficient data to support the safety and efficacy of COVID-19 boosters." It concludes by stating that the surgeon general of Florida, Dr.

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical hold that ...

Everything you need to know about getting a Covid-19 ... dynamic vaccination map showing the number of fully vaccinated people across the U.S. and the number of allocated vaccines that have ...

Hospitalizations and deaths show how severe COVID-19 infections are. Wastewater and emergency room data show changes in COVID-19 spread in a community. Reported case numbers do not show all the ...